|Last Price||Today's Change||52-Week Range||Trading Volume|
|62.35||-0.01 (-0.02%)||54.17 - 72.31||5.3 million (Above Avg)|
Market data as of 4:01PM 11/24/15. Quotes are delayed by at least 15 min.
Teva Reports Positive Top-Line Results from Phase III Trials Evaluating Fluticasone Propionate/Salmeterol and Fluticasone Propionate Multidose Dry Powder Inhalers (MDPIs) in Patients with Asthma
11/19/2015 8:00 AM ET